Not logged in.png)
Share.png)
SaveEffectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China
Jia, Siyue; Liu, Yuanbao; He, Qian; Pan, Hongxing; Liang, Zhenglun; Zhou, Juan; Pan, Yingzi; Liu, Sheng; Wu, Jingjing; Yang, Kun; Zhang, Xuanxuan; Zhao, Yang; Li, Simin; Zhang, Lei; Chen, Li; Yao, Aihua; Lu, Mengyi; Zhu, Fengcai; Li, Jingxin Share Save Share Save Cohort Profile: The Chronic Hepatitis B Infection and Liver Disease (HEPCARE) study in Jiangsu, ChinaJiang, Jie; Song, Ci; Zhu, Liguo; Qian, Jiao; He, Chu; Wang, Hua; Yang, Haitao; Zhu, Fengcai; Yao, Minfang; Zhu, Tao; Cao, Minquan; Ma, Hongxia; Hu, Zhibin; Shen, Hongbing; Zhai, Xiangjun Share Save Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in ChinaZhang, Yang; Wang, Shiyuan; Li, Guifan; Shi, Jinhui; Chang, Xianyun; Zhang, Hao; Zhu, Fengcai; Li, Jingxin; Pan, Hongxing; Sun, Jinfang Share Save Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in ChinaWang, Shiyuan; Zhang, Yang; Li, Guifan; Shi, Jinhui; Chang, Xianyun; Zhang, Hao; Zhu, Fengcai; Li, Jingxin; Chu, Kai; Sun, Jinfang Share Save Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trialJia, Siyue; Shao, Chengwei; Cheng, Xin; Pan, Hongxing; Wang, Zhijian; Xia, Yu; Xu, Jianfang; Huai, Xuefen; Leng, Danjing; Wang, Jiarong; Zhao, Gan; Wang, Bin; Li, Jingxin; Zhu, Fengcai Share Save Share Save Share Save Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialJin, Pengfei; Liu, Qiao; Chen, Wenli; Guo, Xilin; Jiang, Hongmei; Zhang, Ruimei; Ding, Mingdong; Zhang, Kui; Cao, Zhaolan; He, Jiexiao; Jia, Siyue; Wei, Mingwei; Hu, Yuansheng; Cui, Lunbiao; Wang, Jianfeng; Li, Zhuopei; Zhang, Xiaoyin; Xia, Xin; Wu, Yanfei; Zhou, Li; Zhu, Yawen; Gao, Chunjing; Zhang, Tiantian; Zhu, Fengcai; Zeng, Gang; Zhu, Limei; Li, Jingxin Share Save Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohortsSimayi, Aidibai; Chen, Yuxin; Chu, Jinjin; Yu, Huiyan; Zhang, Shihan; Bao, Changjun; Zhu, Fengcai; Jin, Hui; Qin, Yuanfang; Zhen, Qian; Liu, Yong; Zhu, Liguo Share Save Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19Zheng, Hui; Li, Cuidan; Zheng, Xiuyu; Jiang, Hu-Dachuan; Li, Yuqing; Yao, Aihua; Li, Xiaolong; Wang, Feiyu; Liu, Wenqing; Cao, Xiang; Qi, Runjie; Chen, Li; Jin, Lairun; Zhu, Fengcai; Li, Jingxin; Chen, Fei Share Save A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in ChinaHan, Xu; Pan, Hongxing; Jin, Pengfei; Wei, Mingwei; Jia, Siyue; Wang, Wenjuan; Chu, Kai; Gao, Shuyu; Zhou, Li; Li, Jingxin; Zhu, Fengcai Share Save Immunogenicity and safety of an ORF7-deficient skin- attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2atrialPan, Hong-Xing; Qiu, Ling-Xian; Liang, Qi; Chen, Zhen; Zhang, Ming-Lei; Liu, Sheng; Zhong, Guo-Hua; Zhu, Kong-Xin; Liao, Meng-Jun; Hu, Jia-Lei; Li, Jia-Xue; Xu, Jin-Bo; Fan, Yong; Huang, Yue; Su, Ying-Ying; Huang, Shou-Jie; Wang, Wei; Han, Jin-Le; Jia, Ji-Zong; Zhu, Hua; Cheng, Tong; Ye, Xiang-Zhong; Li, Chang-Gui; Wu, Ting; Zhu, Feng-Cai; Zhang, Jun; Xia, Ning-Shao Share Save Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern ChinaHuang, Xingcheng; Zheng, Xiaoxiang; Chen, Lin; Zhuang, Chunlan; Yang, Changlin; Zang, Xia; Wang, Yijun; Jiang, Hanmin; Huang, Xiaomeng; Yan, Qiang; Tang, Zimin; Su, Yingying; Zheng, Zizheng; Wu, Ting; Zhang, Xuefeng; Huang, Yue; Huang, Shoujie; Zhu, Fengcai; Zhang, Jun; Xia, Ningshao Share Save Share Save Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trialZhou, Huan; Zheng, Hui; Peng, Yucai; Su, Yue; Yu, Xuya; Wang, Weixiao; Li, Simin; Ding, Yuzhou; Jiao, Shiping; Wang, Ying; Zhu, Xingyu; Luo, Liping; Dong, Ziyong; Liu, Lu; Zhang, Fan; Wu, Qiang; Li, Jingxin; Zhu, Fengcai Share Save Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled studyTang, Rong; Zeng, Ying; Zhou, Yu; Liang, Qi; Kang, Wei; Yang, Zhonghua; Zheng, Xiaoxiang; Zang, Xia; Pan, Hongxing; Jin, Jing; Zhu, Fengcai Share Save Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control studyJia, Siyue; Yin, Zundong; Pan, Hongxing; Wang, Fuzhen; Liu, Xiaoqiang; Wang, Qing; Zhang, Li; Tang, Jihai; Yang, Hao; Du, Jiangbo; Wang, Zhiguo; Jin, Pengfei; Peng, Zhihang; Tang, Rong; Kang, Guodong; Wang, Xuewen; Li, Simin; Wang, Weixiao; Li, Jingxin; Shen, Hongbing; Zhu, Fengcai Share Save Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical TrialZhu, Yawen; Tang, Rong; Li, Xiaolong; Chen, Xiaoqin; Wang, Xue; Wang, Ying; Wang, Ruijie; Zhu, Fengcai; Li, Jingxin Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
